Write-up of Japan Achievement Awards 2008, day 2

Here are the details of our Japan Deal Awards for 2008, which were announced in February. A write-up of our House Awards was published yesterday.

Takeda Pharmaceutical's $8.5 billion acquisition of the US's Millennium Pharmaceuticals
Acquirer adviser UBS Investment Bank
Target adviser Goldman Sachs

This was a deal which simply ticked all the right boxes in a very complete manner. It was the biggest deal of the year, it made excellent strategic sense and it was flawlessly executed. It also makes sense for the deal of the year to come from the pharmaceutical sector this year, as this sector saw the greatest level of cross-border activity. This deal enables an industry-leading Japanese company Takeda to widen its expertise to include anti-cancer drugs, an area of special expertise at Millennium. The acquisition is extremely complementary to...

¬ Haymarket Media Limited. All rights reserved.

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team subscription (2-5 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at [email protected], or +(852) 2122 5222